Clincosm LogoSign in Get a demo

heart valve disease

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Valve Disease Trial in Puerto Rico, Spain, United States (17mm aortic valve (On-X ), 23mm mitral valve (On-X))

Active, not recruiting
  • Heart Valve Disease
  • 17mm aortic valve (On-X )
  • 23mm mitral valve (On-X)
  • Little Rock, Arkansas
  • +9 more
Sep 13, 2022

Application of Regenerative Heart Valves - ESPOIR

Completed
  • Heart Valve Disease
  • Decellularized human valves
  • Leuven, Belgium
  • +7 more
Apr 25, 2022

Congenital Heart Disease, Heart Valve Disease Trial in Guangzhou (simvastatin)

Recruiting
  • Congenital Heart Disease
  • Heart Valve Disease
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital, Sun Yat-sen University
Mar 17, 2022

Heart Valve Disease Trial in Worldwide (On-X Heart valve replacement, SJM Heart valve replacement)

Completed
  • Heart Valve Disease
  • On-X Heart valve replacement
  • SJM Heart valve replacement
  • Los Angeles, California
  • +27 more
May 23, 2021

Magnetic Resonance Imaging and Fibrosis

Completed
  • Heart Valve Disease
  • +2 more
    • Linkoping, Sweden
      Dept. of Vascular and Cardiothoracic Surgery, University Hospita
    Feb 18, 2021

    Aortic Replacement Using Individualised Regenerative Allografts

    Completed
    • Heart Valve Disease
    • Decellularized human heart valves
    • Leuven, Belgium
    • +7 more
    May 29, 2020

    Cheyne-Stokes Respiration, Heart Valve Disease, Central Sleep Apnea Trial in Nanjing (heart valve replacement)

    Completed
    • Cheyne-Stokes Respiration
    • +2 more
    • heart valve replacement
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Feb 23, 2020

    Disorder of Vitamin C, Atrial Fibrillation, Complications Due to Coronary Artery Bypass Graft Trial in Richmond (Ascorbic Acid,

    Terminated
    Has Results
    • Disorder of Vitamin C
    • +3 more
    • Ascorbic Acid
    • Placebo
    • Richmond, Virginia
      Virginia Commonwealth University Health System
    Mar 28, 2019

    Heart Valve Disease Trial (Aortic valve replacement)

    Withdrawn
    • Heart Valve Disease
    • Aortic valve replacement
    • (no location specified)
    Feb 1, 2019

    Heart Disease, Mitral Regurgitation, Heart Valve Disease Trial in Winston-Salem (Beta-blocker therapy (TOPROL-XL® ))

    Terminated
    • Heart Disease
    • +3 more
    • Beta-blocker therapy (TOPROL-XL® )
    • Winston-Salem, North Carolina
      Wake Forest University Baptist Medical Center
    Aug 10, 2018

    Heart Valve Disease, Coronary Artery Disease Trial in Atlanta (Human fibrinogen concentrate, apheresis platelets)

    Terminated
    Has Results
    • Heart Valve Disease
    • Coronary Artery Disease
    • Human fibrinogen concentrate
    • apheresis platelets
    • Atlanta, Georgia
      Emory University Hospital
    May 23, 2018

    Chronic Symptomatic Functional Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Heart Valve Disease Trial in Worldwide

    Recruiting
    • Chronic Symptomatic Functional Tricuspid Regurgitation
    • +2 more
    • Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
    • Berlin, Germany
    • +10 more
    Feb 6, 2018

    Heart Valve Disease, Heart Septal Defects, Atrial Trial in Chandigarh (Dexmedetomidine, Ketofol(ketamine+propofol))

    Completed
    • Heart Valve Disease
    • Heart Septal Defects, Atrial
    • Chandigarh, India
      Postgraduate Institute of Medical Education and Research
    Nov 2, 2017

    Chronic Symptomatic Functional Tricuspid Regurgitation, Tricuspid Valve Insufficiency, Heart Valve Disease Trial in United

    Unknown status
    • Chronic Symptomatic Functional Tricuspid Regurgitation
    • +2 more
    • Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
    • Los Angeles, California
    • +10 more
    Oct 26, 2017

    D-Dimer Determined Anticoagulation INTENSITY in Mechanical Valve

    Completed
    Has Results
    • Heart Valve Disease
    • Wuhan, Hubei, China
    • +1 more
    Apr 9, 2017

    Heart Valve Disease, Coronary (Artery) Disease Trial in Istanbul (Fraction of inspired oxygen 40%, Fraction of inspired oxygen

    Unknown status
    • Heart Valve Disease
    • Coronary (Artery) Disease
    • Fraction of inspired oxygen 40%
    • Fraction of inspired oxygen 100%
    • Istanbul, Marmara, Turkey
    • +1 more
    Jan 5, 2017

    Delirium, Congenital Heart Disease, Coronary Artery Disease Trial in Baltimore (Remote ischemic pre-conditioning, Delirium

    Completed
    • Delirium
    • +3 more
    • Remote ischemic pre-conditioning
    • Delirium Assessment
    • Baltimore, Maryland
      The Johns Hopkins Hospital
    Aug 10, 2016

    Aortic Valve Stenosis, Heart Valve Disease Trial in Stockholm (4-dimensional volume-rendered computed tomography)

    Completed
    • Aortic Valve Stenosis
    • Heart Valve Disease
    • 4-dimensional volume-rendered computed tomography
    • Stockholm, Sweden
      Department of Cardiothoracic Surgery and Anesthesiology, Karolin
    Jul 7, 2016

    Atrial Fibrillation, Venous Thromboembolism, Heart Valve Disease Trial in Hamilton (Double dose)

    Completed
    • Atrial Fibrillation
    • +3 more
    • Double dose
    • Hamilton, Ontario, Canada
      Thrombosis Service, HHS- General Hospital
    Apr 1, 2016

    Mitral Insufficiency, Heart Valve Disease, Cardiovascular Disease Trial in Worldwide (CardiAQ TMVI System (Transapical DS))

    Terminated
    • Mitral Insufficiency
    • +3 more
    • CardiAQ TMVI System (Transapical DS)
    • Copenhagen, Denmark
    • +8 more
    Mar 29, 2016

    Mitral Insufficiency, Heart Valve Disease, Cardiovascular Disease Trial (CardiAQ TMVI System (Transapical & Transfemoral DS))

    Withdrawn
    • Mitral Insufficiency
    • +3 more
    • CardiAQ TMVI System (Transapical & Transfemoral DS)
    • (no location specified)
    Mar 29, 2016

    Heart Valve Disease, Older Than 18-years-old, Without Any Liver or Kidney Diseases Trial in Guangzhou (CYP2C9;VKORC1)

    Unknown status
    • Heart Valve Disease
    • +2 more
    • CYP2C9;VKORC1
    • Guangzhou, Guangdong, China
      Guangdong General Hospital
    Mar 11, 2016

    Heart Valve Disease Trial in Copenhagen (Integrated rehabilitation)

    Completed
    • Heart Valve Disease
    • Integrated rehabilitation
    • Copenhagen, Denmark
      Rigshospitalet / Copenhagen University Hospital
    Nov 12, 2015

    Atrial Fibrillation, Deep Vein Thrombosis, Pulmonary Embolism Trial in Beijing (Genotype-guided warfarin dosing, Non-genotype

    Unknown status
    • Atrial Fibrillation
    • +3 more
    • Genotype-guided warfarin dosing
    • Non-genotype guided warfarin dosing
    • Beijing, China
      Institute of geriatric Cardiology, General Hospital of People's
    Oct 7, 2013

    The Study of Warfarin Maintenance Dose in Chinese Patients

    Unknown status
    • Atrial Fibrillation
    • +2 more
    • Beijing, China
      Key Laboratory of Clinical Trial Research in Cardiovascular Drug
    Jun 2, 2013